BackKiniksa Pharmaceuticals International Plc. Overview

Kiniksa Pharmaceuticals International Plc. Inventory

Kiniksa Pharmaceuticals International Plc.'s inventory is $73M.

Get informed when a big investor buys or sells

+ Follow
Inventory
$73.14M
231.42% YoYΔ $51.07M vs prior year quarter

Peer average

Loading

Kiniksa Pharmaceuticals International Plc. Inventory History

Loading

Kiniksa Pharmaceuticals International Plc. vs. peers: Inventory Comparison

Loading

Kiniksa Pharmaceuticals International Plc. Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Kiniksa Pharmaceuticals International Plc. (KNSA) FAQ

As of the most recent data (March 2026), KNSA shows a inventory of $73M. That compares with $22M in the prior-year period — up 231.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, KNSA's inventory is now $73M (was $22M) — a 231.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Kiniksa Pharmaceuticals International Plc. is outperforming or lagging.

Tracking KNSA's inventory over time shows whether Kiniksa Pharmaceuticals International Plc. is scaling, shrinking, or reshaping that part of the business. The current reading is $73M That compares with $22M in the prior-year period — up 231.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this inventory page, Stockcircle has Kiniksa Pharmaceuticals International Plc.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $73M) with ownership activity and broader fundamentals.

Kiniksa Pharmaceuticals International Plc.'s inventory is $73M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.